What is Hippocratic AI?
Hippocratic AI operates at the intersection of generative artificial intelligence and clinical operations. By developing specialized AI agents designed to augment healthcare staffing, the company aims to alleviate the systemic pressures currently facing medical institutions worldwide. Its core product, a safety-hardened AI architecture, is engineered to handle complex patient interactions while maintaining the rigorous standards required in clinical environments. The company's market position is defined by its focus on high-stakes, safety-critical applications, distinguishing it from general-purpose AI providers. With strong customer traction and a clear mandate to improve healthcare accessibility, Hippocratic AI is effectively positioning itself as an essential infrastructure layer for the future of digital health.
How much funding has Hippocratic AI raised?
Hippocratic AI has raised a total of $335M across 4 funding rounds:
Angel/Seed
$15M
Series A
$53M
Series B
$141M
Other Financing Round
$126M
Angel/Seed (2023): $15M, investors not publicly disclosed
Series A (2024): $53M led by General Catalyst and Premji Invest
Series B (2025): $141M supported by Andreessen Horowitz, Kleiner Perkins, Premji Invest, and General Catalyst
Other Financing Round (2025): $126M featuring Kleiner Perkins, WellSpan, Avenir, and CapitalG
Key Investors in Hippocratic AI
General Catalyst
A prominent venture capital firm that partners with founders to build enduring enterprises, providing deep sector expertise and operational support to companies at critical inflection points.
Kleiner Perkins
A Menlo Park-based firm with a long history of backing early and growth-stage technology and life science companies, offering both capital and strategic guidance from seed through IPO.
CapitalG
Alphabet's independent growth fund, which provides significant capital and hands-on operational support to transformational companies, leveraging a vast network of Google advisors.
What's next for Hippocratic AI?
With the successful closure of its latest financing round, Hippocratic AI is poised to accelerate its product roadmap and expand its enterprise footprint. The strategic focus will likely shift toward deepening its integration within large-scale health systems and refining its safety protocols to meet evolving regulatory requirements. By leveraging the expertise of its high-profile investor base, the company is well-positioned to navigate the complexities of the healthcare market, scale its operational capacity, and continue its mission of solving the global staffing shortage through technological innovation. Future growth will likely center on expanding the capabilities of its AI agents to support a broader range of clinical workflows, thereby cementing its role as a category-defining leader in the health-tech ecosystem.
See full Hippocratic AI company page
